Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002.
about
The impact of a 6-year comprehensive community trial on the awareness, treatment and control rates of hypertension in Iran: experiences from the Isfahan healthy heart programThe relationship among restless legs syndrome (Willis-Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular diseasePrevalence, Awareness, Treatment, and Control of Hypertension in Romania: Results of the SEPHAR StudyPrevalence of hypertension in china: a cross-sectional study.Prevalence, awareness, treatment and control of hypertension in a self-selected sub-Saharan African urban population: a cross-sectional studyTherapeutic potential of angiotensin receptor blockers in hypertension.Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway.Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determBaroreflex activation for the treatment of hypertension: principles and practice.Preparing for the worst while hoping for the best: the relevance of hope in the heart failure illness trajectory.Why is blood pressure so hard to control in patients with type 2 diabetes?Worldwide epidemic of hypertensionFixed combinations in the management of hypertension: perspectives on lercanidipine-enalaprilThe importance of prompt blood pressure control.Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker.Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older.Screening, treatment, and control of hypertension in US private physician offices, 2003-2004Hypertension treatment and control rates: chart review in an academic family medicine clinic.Blood pressure responder rates versus goal rates: which metric matters?Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes.Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment.Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension.Treatment of hypertension in older persons: what is the evidence?Prevalence, awareness, treatment, and control of hypertension among China's Sichuan Tibetan population: A cross-sectional study.Antihypertensive prescribing: do we have reason to celebrate?Prevalence, awareness, treatment and control of hypertension in the Palestinian population.Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.A comparison of the efficacy and safety of irbesartan/HCTZ combination therapy with irbesartan and HCTZ monotherapy in the treatment of moderate hypertension.Prevalence of the metabolic syndrome in the United States National Health and Nutrition Examination Survey 1999-2002 according to different defining criteria.Awareness of Cardiovascular Risk Factors in U.S. Young Adults Aged 18-39 Years.
P2860
Q30497952-2747476D-9EB8-41E1-8267-874727BF7426Q33755360-FD106BCC-FF38-4AA2-9164-FE6E34FC6501Q34218945-A6F1A1CE-8144-47AE-9F3C-74BD538154F3Q34776080-4E0EC21D-FDC8-4E04-82DE-3865BA1EC199Q36208603-9DC262DC-AB50-4DD7-812E-47A907C8F697Q36491825-263ED357-56AB-46B1-932D-BAFB708B3EACQ36579769-A05C0633-3347-40F1-9438-8153A83FE13EQ36621460-4CCA05B2-B8B0-4467-BDBB-A729E643FDB5Q36634303-41E017DE-F8C3-476E-AD02-091C676EED65Q36839029-AE1E835F-311D-40BD-AE23-A4B77519ABC8Q36904456-E03C15EE-19EC-4188-B3EC-1246EA589469Q36921836-42757CE8-015E-47EF-B614-33F0B238F1D5Q37004035-947BE789-6E68-44A3-9141-3BA1EE29A486Q37050147-C38E03BB-FA00-4ED7-9359-D21BCCC0EAE9Q37050156-55BE4582-6652-4F4C-BA50-C43A0601E715Q37126630-1382528A-28EC-419A-8320-C0F6D585268AQ37166271-F1911DC0-1115-4E58-9206-0E8CC1E16754Q37283221-4062BA26-9A5D-412A-A327-DF974984F218Q37418547-39E3BBC5-5F90-4D9D-8737-CB05077B16BDQ37435002-B0841E7F-80B3-45BD-B512-6C8DBC263405Q37812140-476BC5CB-30E1-4903-98AD-C81A76E734FBQ37959152-6DB69620-FCEA-402B-88F7-C0300A07DC28Q38199361-9ECA764B-B960-44C6-BC24-A708E2D8AB40Q40673994-403A546F-1A4D-4E8D-8176-A91F88EE4469Q43220327-E7FB12FE-DF8E-422A-A39D-0CB91CCBB6D4Q43717532-2C6660AB-5EB6-492E-8EFC-942CB8BEF31AQ46068475-00160978-C1F7-4E12-A7E6-1ED69CCBC670Q46956236-A3F6CD6E-2F75-4C1E-B02B-EE80ABEF6B2EQ48452057-479B9E1E-C0AF-437D-9708-66B8B6181277Q50056580-1CFF812E-8674-4B56-A9D6-D9340D4B3481
P2860
Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Prevalence, awareness, treatme ...... Examination Survey 2001-2002.
@en
Prevalence, awareness, treatme ...... Examination Survey 2001-2002.
@nl
type
label
Prevalence, awareness, treatme ...... Examination Survey 2001-2002.
@en
Prevalence, awareness, treatme ...... Examination Survey 2001-2002.
@nl
prefLabel
Prevalence, awareness, treatme ...... Examination Survey 2001-2002.
@en
Prevalence, awareness, treatme ...... Examination Survey 2001-2002.
@nl
P2093
P2860
P1476
Prevalence, awareness, treatme ...... Examination Survey 2001-2002.
@en
P2093
Chu-Pak Lau
Karen S L Lam
Kwok Leung Ong
Yu Bun Man
P2860
P356
10.1111/J.1524-6175.2006.04895.X
P577
2006-02-01T00:00:00Z